Altrazeal Life Sciences Inc.

CIK 1168220 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Altrazeal Life Sciences Inc..

Recent SEC filings

FiledFormAccession number
Sep 18, 2023D0001168220-23-000003
Nov 25, 2019D0001168220-19-000001
Mar 5, 2019EFFECT9999999995-19-000366
Mar 5, 2019EFFECT9999999995-19-000364
Mar 5, 2019EFFECT9999999995-19-000363
Mar 5, 2019EFFECT9999999995-19-000365
Mar 1, 2019POS AM0001140361-19-004261
Mar 1, 2019S-8 POS0001140361-19-004248
Mar 1, 2019S-8 POS0001140361-19-004266
Mar 1, 2019POS AM0001140361-19-004258
Mar 1, 2019S-8 POS0001140361-19-004260
Mar 1, 2019S-8 POS0001140361-19-004252
Mar 1, 201915-12G0001140361-19-004267
Mar 1, 2019POS AM0001140361-19-004256
Mar 1, 2019S-8 POS0001140361-19-004262
Mar 1, 2019POS AM0001140361-19-004253
Mar 1, 2019S-8 POS0001140361-19-004263
Mar 1, 2019S-8 POS0001140361-19-004257
Mar 1, 2019S-8 POS0001140361-19-004264
Feb 5, 20198-K0001140361-19-002500
Dec 7, 20188-K0001168220-18-000033
Nov 14, 201810-Q0001168220-18-000031
Aug 14, 201810-Q0001168220-18-000025
Jun 12, 20188-K0001168220-18-000021
May 15, 201810-Q0001168220-18-000017